世界の脂質活性医薬品成分市場2020年:製造業者別、地域別、種類・用途別

【英語タイトル】Global Lipids Active Pharmaceutical Ingredient Market 2020 by Manufacturers, Regions, Type and Application, Forecast to 2025

GlobalInfoResearchが出版した調査資料(GIR20SP05529)・商品コード:GIR20SP05529
・発行会社(調査会社):GlobalInfoResearch
・発行日:2020年9月23日(※2024年版があります。お問い合わせください)
・ページ数:100
・レポート言語:英語
・レポート形式:PDF
・納品方法:Eメール
・調査対象地域:グローバル
・産業分野:化学、材料
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD3,480 ⇒換算¥515,040見積依頼/購入/質問フォーム
Multi User(10名様閲覧用)USD5,220 ⇒換算¥772,560見積依頼/購入/質問フォーム
Corporate User(同一法人内共有可)USD6,960 ⇒換算¥1,030,080見積依頼/購入/質問フォーム
販売価格オプションの説明
※お支払金額:換算金額(日本円)+消費税
※納期:即日〜2営業日(3日以上かかる場合は別途表記又はご連絡)
※お支払方法:納品日+5日以内に請求書を発行・郵送(請求書発行日より2ヶ月以内に銀行振込、振込先:三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能)
本調査レポートでは、脂質活性医薬品成分の世界市場を広く調査・分析し、今後の市場展望をまとめております。脂質活性医薬品成分の種類別市場規模(単純脂質、複合脂質、派生脂質)、用途別市場規模(循環器疾患、炎症性疾患、その他)、地域別市場規模(北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど)、市場動向、メーカー別販売量と市場シェア、販売チャネルなどの情報を掲載しています。
・市場概要
・メーカー情報(販売量、市場シェア、製品概要、SWOT分析):CordenPharma International、Esperion Therapeutics、Sancilio&Company、Avanti Polar Lipids、Merck KGaA、VAV Life Sciences、Cerbios-Pharma SA、Cayman Chemical
・地域別グローバル市場分析 2015年-2020年
・脂質活性医薬品成分の北米市場(アメリカ、カナダ、メキシコ)
・脂質活性医薬品成分のヨーロッパ市場(ドイツ、イギリス、フランス、ロシア、イタリア)
・脂質活性医薬品成分のアジア市場(中国、日本、韓国、インド、東南アジア、オーストラリア)
・脂質活性医薬品成分の南米市場(ブラジル、アルゼンチン)
・脂質活性医薬品成分の中東・アフリカ市場(サウジアラビア、トルコ、エジプト、南アフリカ)
・種類別分析:単純脂質、複合脂質、派生脂質
・用途別分析:循環器疾患、炎症性疾患、その他
・地域別市場規模予測 2021年-2025年
・販売チャネル、流通業者、代理店
・調査の結果・結論
【レポートの概要】

Market Overview
The Lipids Active Pharmaceutical Ingredient market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

The global Lipids Active Pharmaceutical Ingredient market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of XX%% in the forecast period of 2020 to 2025 and will expected to reach USD XX million by 2025, from USD XX million in 2019.

Market segmentation
Lipids Active Pharmaceutical Ingredient market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.

By Type, Lipids Active Pharmaceutical Ingredient market has been segmented into
Simple Lipids
Compound Lipids
Derived Lipids

By Application, Lipids Active Pharmaceutical Ingredient has been segmented into:
Cardiovascular Disease
Inflammatory Diseases
Others

Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global Lipids Active Pharmaceutical Ingredient market presented in the report. This section sheds light on the sales growth of different regional and country-level Lipids Active Pharmaceutical Ingredient markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global Lipids Active Pharmaceutical Ingredient market.

The report offers in-depth assessment of the growth and other aspects of the Lipids Active Pharmaceutical Ingredient market in important countries (regions), including:
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, etc.)
Middle East & Africa (Saudi Arabia, Egypt, Nigeria and South Africa)

Competitive Landscape and Lipids Active Pharmaceutical Ingredient Market Share Analysis
Lipids Active Pharmaceutical Ingredient competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, Lipids Active Pharmaceutical Ingredient sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the Lipids Active Pharmaceutical Ingredient sales, revenue and market share for each player covered in this report.

The major players covered in Lipids Active Pharmaceutical Ingredient are:
CordenPharma International
Esperion Therapeutics
Sancilio&Company
Avanti Polar Lipids
Merck KGaA
VAV Life Sciences
Cerbios-Pharma SA
Cayman Chemical

Among other players domestic and global, Lipids Active Pharmaceutical Ingredient market share data is available for global, North America, Europe, Asia-Pacific, Middle East and Africa and South America separately. Global Info Research analysts understand competitive strengths and provide competitive analysis for each competitor separately.

The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Lipids Active Pharmaceutical Ingredient product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Lipids Active Pharmaceutical Ingredient, with price, sales, revenue and global market share of Lipids Active Pharmaceutical Ingredient in 2018 and 2019.
Chapter 3, the Lipids Active Pharmaceutical Ingredient competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Lipids Active Pharmaceutical Ingredient breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2015 to 2020.
Chapter 5, 6, 7, 8 and 9, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2015 to 2020.
Chapter 10 and 11, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2015 to 2020.
Chapter 12, Lipids Active Pharmaceutical Ingredient market forecast, by regions, type and application, with sales and revenue, from 2020 to 2025.
Chapter 13, 14 and 15, to describe Lipids Active Pharmaceutical Ingredient sales channel, distributors, customers, research findings and conclusion, appendix and data source.

【レポートの目次】

1 Market Overview
1.1 Lipids Active Pharmaceutical Ingredient Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Lipids Active Pharmaceutical Ingredient Revenue by Type: 2015 VS 2019 VS 2025
1.2.2 Simple Lipids
1.2.3 Compound Lipids
1.2.4 Derived Lipids
1.3 Market Analysis by Application
1.3.1 Overview: Global Lipids Active Pharmaceutical Ingredient Revenue by Application: 2015 VS 2019 VS 2025
1.3.2 Cardiovascular Disease
1.3.3 Inflammatory Diseases
1.3.4 Others
1.4 Overview of Global Lipids Active Pharmaceutical Ingredient Market
1.4.1 Global Lipids Active Pharmaceutical Ingredient Market Status and Outlook (2015-2025)
1.4.2 North America (United States, Canada and Mexico)
1.4.3 Europe (Germany, France, United Kingdom, Russia and Italy)
1.4.4 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.5 South America, Middle East & Africa
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
2.1 CordenPharma International
2.1.1 CordenPharma International Details
2.1.2 CordenPharma International Major Business
2.1.3 CordenPharma International SWOT Analysis
2.1.4 CordenPharma International Product and Services
2.1.5 CordenPharma International Lipids Active Pharmaceutical Ingredient Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.2 Esperion Therapeutics
2.2.1 Esperion Therapeutics Details
2.2.2 Esperion Therapeutics Major Business
2.2.3 Esperion Therapeutics SWOT Analysis
2.2.4 Esperion Therapeutics Product and Services
2.2.5 Esperion Therapeutics Lipids Active Pharmaceutical Ingredient Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.3 Sancilio&Company
2.3.1 Sancilio&Company Details
2.3.2 Sancilio&Company Major Business
2.3.3 Sancilio&Company SWOT Analysis
2.3.4 Sancilio&Company Product and Services
2.3.5 Sancilio&Company Lipids Active Pharmaceutical Ingredient Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.4 Avanti Polar Lipids
2.4.1 Avanti Polar Lipids Details
2.4.2 Avanti Polar Lipids Major Business
2.4.3 Avanti Polar Lipids SWOT Analysis
2.4.4 Avanti Polar Lipids Product and Services
2.4.5 Avanti Polar Lipids Lipids Active Pharmaceutical Ingredient Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.5 Merck KGaA
2.5.1 Merck KGaA Details
2.5.2 Merck KGaA Major Business
2.5.3 Merck KGaA SWOT Analysis
2.5.4 Merck KGaA Product and Services
2.5.5 Merck KGaA Lipids Active Pharmaceutical Ingredient Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.6 VAV Life Sciences
2.6.1 VAV Life Sciences Details
2.6.2 VAV Life Sciences Major Business
2.6.3 VAV Life Sciences Product and Services
2.6.4 VAV Life Sciences Lipids Active Pharmaceutical Ingredient Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.7 Cerbios-Pharma SA
2.7.1 Cerbios-Pharma SA Details
2.7.2 Cerbios-Pharma SA Major Business
2.7.3 Cerbios-Pharma SA Product and Services
2.7.4 Cerbios-Pharma SA Lipids Active Pharmaceutical Ingredient Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.8 Cayman Chemical
2.8.1 Cayman Chemical Details
2.8.2 Cayman Chemical Major Business
2.8.3 Cayman Chemical Product and Services
2.8.4 Cayman Chemical Lipids Active Pharmaceutical Ingredient Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
3 Sales, Revenue and Market Share by Manufacturer
3.1 Global Lipids Active Pharmaceutical Ingredient Sales and Market Share by Manufacturer (2018-2019)
3.2 Global Lipids Active Pharmaceutical Ingredient Revenue and Market Share by Manufacturer (2018-2019)
3.3 Market Concentration Rate
3.3.1 Top 3 Lipids Active Pharmaceutical Ingredient Manufacturer Market Share in 2019
3.3.2 Top 6 Lipids Active Pharmaceutical Ingredient Manufacturer Market Share in 2019
3.4 Market Competition Trend
4 Global Market Analysis by Regions
4.1 Global Lipids Active Pharmaceutical Ingredient Sales, Revenue and Market Share by Regions
4.1.1 Global Lipids Active Pharmaceutical Ingredient Sales and Market Share by Regions (2015-2020)
4.1.2 Global Lipids Active Pharmaceutical Ingredient Revenue and Market Share by Regions (2015-2020)
4.2 North America Lipids Active Pharmaceutical Ingredient Sales and Growth Rate (2015-2020)
4.3 Europe Lipids Active Pharmaceutical Ingredient Sales and Growth Rate (2015-2020)
4.4 Asia-Pacific Lipids Active Pharmaceutical Ingredient Sales and Growth Rate (2015-2020)
4.5 South America Lipids Active Pharmaceutical Ingredient Sales and Growth Rate (2015-2020)
4.6 Middle East and Africa Lipids Active Pharmaceutical Ingredient Sales and Growth Rate (2015-2020)
5 North America by Country
5.1 North America Lipids Active Pharmaceutical Ingredient Sales, Revenue and Market Share by Country
5.1.1 North America Lipids Active Pharmaceutical Ingredient Sales and Market Share by Country (2015-2020)
5.1.2 North America Lipids Active Pharmaceutical Ingredient Revenue and Market Share by Country (2015-2020)
5.2 United States Lipids Active Pharmaceutical Ingredient Sales and Growth Rate (2015-2020)
5.3 Canada Lipids Active Pharmaceutical Ingredient Sales and Growth Rate (2015-2020)
5.4 Mexico Lipids Active Pharmaceutical Ingredient Sales and Growth Rate (2015-2020)
6 Europe by Country
6.1 Europe Lipids Active Pharmaceutical Ingredient Sales, Revenue and Market Share by Country
6.1.1 Europe Lipids Active Pharmaceutical Ingredient Sales and Market Share by Country (2015-2020)
6.1.2 Europe Lipids Active Pharmaceutical Ingredient Revenue and Market Share by Country (2015-2020)
6.2 Germany Lipids Active Pharmaceutical Ingredient Sales and Growth Rate (2015-2020)
6.3 UK Lipids Active Pharmaceutical Ingredient Sales and Growth Rate (2015-2020)
6.4 France Lipids Active Pharmaceutical Ingredient Sales and Growth Rate (2015-2020)
6.5 Russia Lipids Active Pharmaceutical Ingredient Sales and Growth Rate (2015-2020)
6.6 Italy Lipids Active Pharmaceutical Ingredient Sales and Growth Rate (2015-2020)
7 Asia-Pacific by Regions
7.1 Asia-Pacific Lipids Active Pharmaceutical Ingredient Sales, Revenue and Market Share by Regions
7.1.1 Asia-Pacific Lipids Active Pharmaceutical Ingredient Sales and Market Share by Regions (2015-2020)
7.1.2 Asia-Pacific Lipids Active Pharmaceutical Ingredient Revenue and Market Share by Regions (2015-2020)
7.2 China Lipids Active Pharmaceutical Ingredient Sales and Growth Rate (2015-2020)
7.3 Japan Lipids Active Pharmaceutical Ingredient Sales and Growth Rate (2015-2020)
7.4 Korea Lipids Active Pharmaceutical Ingredient Sales and Growth Rate (2015-2020)
7.5 India Lipids Active Pharmaceutical Ingredient Sales and Growth Rate (2015-2020)
7.6 Southeast Asia Lipids Active Pharmaceutical Ingredient Sales and Growth Rate (2015-2020)
7.7 Australia Lipids Active Pharmaceutical Ingredient Sales and Growth Rate (2015-2020)
8 South America by Country
8.1 South America Lipids Active Pharmaceutical Ingredient Sales, Revenue and Market Share by Country
8.1.1 South America Lipids Active Pharmaceutical Ingredient Sales and Market Share by Country (2015-2020)
8.1.2 South America Lipids Active Pharmaceutical Ingredient Revenue and Market Share by Country (2015-2020)
8.2 Brazil Lipids Active Pharmaceutical Ingredient Sales and Growth Rate (2015-2020)
8.3 Argentina Lipids Active Pharmaceutical Ingredient Sales and Growth Rate (2015-2020)
9 Middle East & Africa by Countries
9.1 Middle East & Africa Lipids Active Pharmaceutical Ingredient Sales, Revenue and Market Share by Country
9.1.1 Middle East & Africa Lipids Active Pharmaceutical Ingredient Sales and Market Share by Country (2015-2020)
9.1.2 Middle East & Africa Lipids Active Pharmaceutical Ingredient Revenue and Market Share by Country (2015-2020)
9.2 Saudi Arabia Lipids Active Pharmaceutical Ingredient Sales and Growth Rate (2015-2020)
9.3 Turkey Lipids Active Pharmaceutical Ingredient Sales and Growth Rate (2015-2020)
9.4 Egypt Lipids Active Pharmaceutical Ingredient Sales and Growth Rate (2015-2020)
9.5 South Africa Lipids Active Pharmaceutical Ingredient Sales and Growth Rate (2015-2020)
10 Market Segment by Type
10.1 Global Lipids Active Pharmaceutical Ingredient Sales and Market Share by Type (2015-2020)
10.2 Global Lipids Active Pharmaceutical Ingredient Revenue and Market Share by Type (2015-2020)
10.3 Global Lipids Active Pharmaceutical Ingredient Price by Type (2015-2020)
11 Global Lipids Active Pharmaceutical Ingredient Market Segment by Application
11.1 Global Lipids Active Pharmaceutical Ingredient Sales Market Share by Application (2015-2020)
11.2 Global Lipids Active Pharmaceutical Ingredient Revenue Market Share by Application (2015-2020)
11.3 Global Lipids Active Pharmaceutical Ingredient Price by Application (2015-2020)
12 Market Forecast
12.1 Global Lipids Active Pharmaceutical Ingredient Sales, Revenue and Growth Rate (2021-2025)
12.2 Lipids Active Pharmaceutical Ingredient Market Forecast by Regions (2021-2025)
12.2.1 North America Lipids Active Pharmaceutical Ingredient Market Forecast (2021-2025)
12.2.2 Europe Lipids Active Pharmaceutical Ingredient Market Forecast (2021-2025)
12.2.3 Asia-Pacific Lipids Active Pharmaceutical Ingredient Market Forecast (2021-2025)
12.2.4 South America Lipids Active Pharmaceutical Ingredient Market Forecast (2021-2025)
12.2.5 Middle East & Africa Lipids Active Pharmaceutical Ingredient Market Forecast (2021-2025)
12.3 Lipids Active Pharmaceutical Ingredient Market Forecast by Type (2021-2025)
12.3.1 Global Lipids Active Pharmaceutical Ingredient Sales Forecast by Type (2021-2025)
12.3.2 Global Lipids Active Pharmaceutical Ingredient Market Share Forecast by Type (2021-2025)
12.4 Lipids Active Pharmaceutical Ingredient Market Forecast by Application (2021-2025)
12.4.1 Global Lipids Active Pharmaceutical Ingredient Sales Forecast by Application (2021-2025)
12.4.2 Global Lipids Active Pharmaceutical Ingredient Market Share Forecast by Application (2021-2025)
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Data Source
15.3 Disclaimer
15.4 About US

List of Tables
Table 1. Global Lipids Active Pharmaceutical Ingredient Revenue (USD Million) by Type: 2015 VS 2019 VS 2025
Table 2. Breakdown of Lipids Active Pharmaceutical Ingredient by Company Type (Tier 1, Tier 2 and Tier 3)
Table 3. Global Lipids Active Pharmaceutical Ingredient Market Size and Growth Estimation in Various Scenarios in 2020
Table 4. Global Lipids Active Pharmaceutical Ingredient Revenue (USD Million) by Application: 2015 VS 2019 VS 2025
Table 5. Market Opportunities in Next Few Years
Table 6. Market Risks Analysis
Table 7. Market Drivers
Table 8. CordenPharma International Basic Information, Manufacturing Base and Competitors
Table 9. CordenPharma International Lipids Active Pharmaceutical Ingredient Major Business
Table 10. CordenPharma International Lipids Active Pharmaceutical Ingredient Total Revenue (USD Million) (2018-2019)
Table 11. CordenPharma International SWOT Analysis
Table 12. CordenPharma International Lipids Active Pharmaceutical Ingredient Product and Services
Table 13. CordenPharma International Lipids Active Pharmaceutical Ingredient Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 14. Esperion Therapeutics Basic Information, Manufacturing Base and Competitors
Table 15. Esperion Therapeutics Lipids Active Pharmaceutical Ingredient Major Business
Table 16. Esperion Therapeutics Lipids Active Pharmaceutical Ingredient Total Revenue (USD Million) (2018-2019)
Table 17. Esperion Therapeutics SWOT Analysis
Table 18. Esperion Therapeutics Lipids Active Pharmaceutical Ingredient Product and Services
Table 19. Esperion Therapeutics Lipids Active Pharmaceutical Ingredient Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 20. Sancilio&Company Basic Information, Manufacturing Base and Competitors
Table 21. Sancilio&Company Lipids Active Pharmaceutical Ingredient Major Business
Table 22. Sancilio&Company Lipids Active Pharmaceutical Ingredient Total Revenue (USD Million) (2018-2019)
Table 23. Sancilio&Company SWOT Analysis
Table 24. Sancilio&Company Lipids Active Pharmaceutical Ingredient Product and Services
Table 25. Sancilio&Company Lipids Active Pharmaceutical Ingredient Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 26. Avanti Polar Lipids Basic Information, Manufacturing Base and Competitors
Table 27. Avanti Polar Lipids Lipids Active Pharmaceutical Ingredient Major Business
Table 28. Avanti Polar Lipids Lipids Active Pharmaceutical Ingredient Total Revenue (USD Million) (2018-2019)
Table 29. Avanti Polar Lipids SWOT Analysis
Table 30. Avanti Polar Lipids Lipids Active Pharmaceutical Ingredient Product and Services
Table 31. Avanti Polar Lipids Lipids Active Pharmaceutical Ingredient Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 32. Merck KGaA Basic Information, Manufacturing Base and Competitors
Table 33. Merck KGaA Lipids Active Pharmaceutical Ingredient Major Business
Table 34. Merck KGaA Lipids Active Pharmaceutical Ingredient Total Revenue (USD Million) (2018-2019)
Table 35. Merck KGaA SWOT Analysis
Table 36. Merck KGaA Lipids Active Pharmaceutical Ingredient Product and Services
Table 37. Merck KGaA Lipids Active Pharmaceutical Ingredient Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 38. VAV Life Sciences Basic Information, Manufacturing Base and Competitors
Table 39. VAV Life Sciences Lipids Active Pharmaceutical Ingredient Major Business
Table 40. VAV Life Sciences Lipids Active Pharmaceutical Ingredient Total Revenue (USD Million) (2018-2019)
Table 41. VAV Life Sciences SWOT Analysis
Table 42. VAV Life Sciences Lipids Active Pharmaceutical Ingredient Product and Services
Table 43. VAV Life Sciences Lipids Active Pharmaceutical Ingredient Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 44. Cerbios-Pharma SA Basic Information, Manufacturing Base and Competitors
Table 45. Cerbios-Pharma SA Lipids Active Pharmaceutical Ingredient Major Business
Table 46. Cerbios-Pharma SA Lipids Active Pharmaceutical Ingredient Total Revenue (USD Million) (2018-2019)
Table 47. Cerbios-Pharma SA SWOT Analysis
Table 48. Cerbios-Pharma SA Lipids Active Pharmaceutical Ingredient Product and Services
Table 49. Cerbios-Pharma SA Lipids Active Pharmaceutical Ingredient Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 50. Cayman Chemical Basic Information, Manufacturing Base and Competitors
Table 51. Cayman Chemical Lipids Active Pharmaceutical Ingredient Major Business
Table 52. Cayman Chemical Lipids Active Pharmaceutical Ingredient Total Revenue (USD Million) (2018-2019)
Table 53. Cayman Chemical SWOT Analysis
Table 54. Cayman Chemical Lipids Active Pharmaceutical Ingredient Product and Services
Table 55. Cayman Chemical Lipids Active Pharmaceutical Ingredient Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 56. Global Lipids Active Pharmaceutical Ingredient Sales by Manufacturer (2018-2019) (Kiloton)
Table 57. Global Lipids Active Pharmaceutical Ingredient Revenue by Manufacturer (2018-2019) (USD Million)
Table 58. Global Lipids Active Pharmaceutical Ingredient Sales by Regions (2015-2020) (Kiloton)
Table 59. Global Lipids Active Pharmaceutical Ingredient Sales Market Share by Regions (2015-2020)
Table 60. Global Lipids Active Pharmaceutical Ingredient Revenue by Regions (2015-2020) (USD Million)
Table 61. North America Lipids Active Pharmaceutical Ingredient Sales by Countries (2015-2020) (Kiloton)
Table 62. North America Lipids Active Pharmaceutical Ingredient Sales Market Share by Countries (2015-2020)
Table 63. North America Lipids Active Pharmaceutical Ingredient Revenue by Countries (2015-2020) (USD Million)
Table 64. North America Lipids Active Pharmaceutical Ingredient Revenue Market Share by Countries (2015-2020)
Table 65. Europe Lipids Active Pharmaceutical Ingredient Sales by Countries (2015-2020) (Kiloton)
Table 66. Europe Lipids Active Pharmaceutical Ingredient Sales Market Share by Countries (2015-2020)
Table 67. Europe Lipids Active Pharmaceutical Ingredient Revenue by Countries (2015-2020) (USD Million)
Table 68. Asia-Pacific Lipids Active Pharmaceutical Ingredient Sales by Regions (2015-2020) (Kiloton)
Table 69. Asia-Pacific Lipids Active Pharmaceutical Ingredient Sales Market Share by Regions (2015-2020)
Table 70. Asia-Pacific Lipids Active Pharmaceutical Ingredient Revenue by Regions (2015-2020) (USD Million)
Table 71. South America Lipids Active Pharmaceutical Ingredient Sales by Countries (2015-2020) (Kiloton)
Table 72. South America Lipids Active Pharmaceutical Ingredient Sales Market Share by Countries (2015-2020)
Table 73. South America Lipids Active Pharmaceutical Ingredient Revenue by Countries (2015-2020) (USD Million)
Table 74. South America Lipids Active Pharmaceutical Ingredient Revenue Market Share by Countries (2015-2020)
Table 75. Middle East & Africa Lipids Active Pharmaceutical Ingredient Sales by Countries (2015-2020) (Kiloton)
Table 76. Middle East & Africa Lipids Active Pharmaceutical Ingredient Sales Market Share by Countries (2015-2020)
Table 77. Middle East & Africa Lipids Active Pharmaceutical Ingredient Revenue by Countries (2015-2020) (USD Million)
Table 78. Middle East & Africa Lipids Active Pharmaceutical Ingredient Revenue Market Share by Countries (2015-2020)
Table 79. Global Lipids Active Pharmaceutical Ingredient Sales by Type (2015-2020) (Kiloton)
Table 80. Global Lipids Active Pharmaceutical Ingredient Sales Share by Type (2015-2020)
Table 81. Global Lipids Active Pharmaceutical Ingredient Revenue by Type (2015-2020) (USD Million)
Table 82. Global Lipids Active Pharmaceutical Ingredient Revenue Share by Type (2015-2020)
Table 83. Global Lipids Active Pharmaceutical Ingredient Sales by Application (2015-2020) (Kiloton)
Table 84. Global Lipids Active Pharmaceutical Ingredient Sales Share by Application (2015-2020)
Table 85. Global Lipids Active Pharmaceutical Ingredient Sales Forecast by Regions (2021-2025) (Kiloton)
Table 86. Global Lipids Active Pharmaceutical Ingredient Market Share Forecast by Regions (2021-2025)
Table 87. Global Lipids Active Pharmaceutical Ingredient Sales Forecast by Type (2021-2025) (Kiloton)
Table 88. Global Lipids Active Pharmaceutical Ingredient Market Share Forecast by Type (2021-2025)
Table 89. Global Lipids Active Pharmaceutical Ingredient Sales Forecast by Application (2021-2025)
Table 90. Global Lipids Active Pharmaceutical Ingredient Market Share Forecast by Application (2021-2025)
Table 91. Direct Channel Pros & Cons
Table 92. Indirect Channel Pros & Cons
Table 93. Distributors/Traders/ Dealers List
List of Figures
Figure 1. Lipids Active Pharmaceutical Ingredient Picture
Figure 2. Global Sales Market Share of Lipids Active Pharmaceutical Ingredient by Type in 2019
Figure 3. Simple Lipids Picture
Figure 4. Compound Lipids Picture
Figure 5. Derived Lipids Picture
Figure 6. Lipids Active Pharmaceutical Ingredient Sales Market Share by Application in 2019
Figure 7. Cardiovascular Disease Picture
Figure 8. Inflammatory Diseases Picture
Figure 9. Others Picture
Figure 10. Global Lipids Active Pharmaceutical Ingredient Market Status and Outlook (2015-2025) (USD Million)
Figure 11. United States Lipids Active Pharmaceutical Ingredient Revenue (Value) and Growth Rate (2015-2025)
Figure 12. Canada Lipids Active Pharmaceutical Ingredient Revenue (Value) and Growth Rate (2015-2025)
Figure 13. Mexico Lipids Active Pharmaceutical Ingredient Revenue (Value) and Growth Rate (2015-2025)
Figure 14. Germany Lipids Active Pharmaceutical Ingredient Revenue (Value) and Growth Rate (2015-2025)
Figure 15. France Lipids Active Pharmaceutical Ingredient Revenue (Value) and Growth Rate (2015-2025)
Figure 16. UK Lipids Active Pharmaceutical Ingredient Revenue (Value) and Growth Rate (2015-2025)
Figure 17. Russia Lipids Active Pharmaceutical Ingredient Revenue (Value) and Growth Rate (2015-2025)
Figure 18. Italy Lipids Active Pharmaceutical Ingredient Revenue (Value) and Growth Rate (2015-2025)
Figure 19. China Lipids Active Pharmaceutical Ingredient Revenue (Value) and Growth Rate (2015-2025)
Figure 20. Japan Lipids Active Pharmaceutical Ingredient Revenue (Value) and Growth Rate (2015-2025)
Figure 21. Korea Lipids Active Pharmaceutical Ingredient Revenue (Value) and Growth Rate (2015-2025)
Figure 22. India Lipids Active Pharmaceutical Ingredient Revenue (Value) and Growth Rate (2015-2025)
Figure 23. Southeast Asia Lipids Active Pharmaceutical Ingredient Revenue (Value) and Growth Rate (2015-2025)
Figure 24. Australia Lipids Active Pharmaceutical Ingredient Revenue (Value) and Growth Rate (2015-2025) (USD Million)
Figure 25. Brazil Lipids Active Pharmaceutical Ingredient Revenue (Value) and Growth Rate (2015-2025)
Figure 26. Egypt Lipids Active Pharmaceutical Ingredient Revenue (Value) and Growth Rate (2015-2025)
Figure 27. Saudi Arabia Lipids Active Pharmaceutical Ingredient Revenue (Value) and Growth Rate (2015-2025)
Figure 28. South Africa Lipids Active Pharmaceutical Ingredient Revenue (Value) and Growth Rate (2015-2025)
Figure 29. Turkey Lipids Active Pharmaceutical Ingredient Revenue (Value) and Growth Rate (2015-2025)
Figure 30. Global Lipids Active Pharmaceutical Ingredient Sales Market Share by Manufacturer in 2019
Figure 31. Global Lipids Active Pharmaceutical Ingredient Revenue Market Share by Manufacturer in 2019
Figure 32. Top 3 Lipids Active Pharmaceutical Ingredient Manufacturer (Revenue) Market Share in 2019
Figure 33. Top 6 Lipids Active Pharmaceutical Ingredient Manufacturer (Revenue) Market Share in 2019
Figure 34. Key Manufacturer Market Share Trend
Figure 35. Global Lipids Active Pharmaceutical Ingredient Sales and Growth Rate (2015-2020) (Kiloton)
Figure 36. Global Lipids Active Pharmaceutical Ingredient Revenue and Growth Rate (2015-2020) (USD Million)
Figure 37. Global Lipids Active Pharmaceutical Ingredient Revenue Market Share by Regions (2015-2020)
Figure 38. Global Lipids Active Pharmaceutical Ingredient Revenue Market Share by Regions in 2018
Figure 39. North America Lipids Active Pharmaceutical Ingredient Sales and Growth Rate (2015-2020)
Figure 40. Europe Lipids Active Pharmaceutical Ingredient Sales and Growth Rate (2015-2020)
Figure 41. Asia-Pacific Lipids Active Pharmaceutical Ingredient Sales and Growth Rate (2015-2020)
Figure 42. South America Lipids Active Pharmaceutical Ingredient Sales and Growth Rate (2015-2020)
Figure 43. Middle East & Africa Lipids Active Pharmaceutical Ingredient Sales and Growth Rate (2015-2020)
Figure 44. North America Lipids Active Pharmaceutical Ingredient Revenue and Growth Rate (2015-2020) (USD Million)
Figure 45. North America Lipids Active Pharmaceutical Ingredient Sales Market Share by Countries (2015-2020)
Figure 46. North America Lipids Active Pharmaceutical Ingredient Sales Market Share by Countries in 2018
Figure 47. North America Lipids Active Pharmaceutical Ingredient Revenue Market Share by Countries (2015-2020) (USD Million)
Figure 48. North America Lipids Active Pharmaceutical Ingredient Revenue Market Share by Countries in 2018
Figure 49. United States Lipids Active Pharmaceutical Ingredient Sales and Growth Rate (2015-2020) (Kiloton)
Figure 50. Canada Lipids Active Pharmaceutical Ingredient Sales and Growth Rate (2015-2020) (Kiloton)
Figure 51. Mexico Lipids Active Pharmaceutical Ingredient Sales and Growth Rate (2015-2020) (Kiloton)
Figure 52. Europe Lipids Active Pharmaceutical Ingredient Revenue and Growth Rate (2015-2020) (USD Million)
Figure 53. Europe Lipids Active Pharmaceutical Ingredient Revenue Market Share by Countries (2015-2020)
Figure 54. Europe Lipids Active Pharmaceutical Ingredient Revenue Market Share by Countries in 2019
Figure 55. Germany Lipids Active Pharmaceutical Ingredient Sales and Growth Rate (2015-2020) (Kiloton)
Figure 56. UK Lipids Active Pharmaceutical Ingredient Sales and Growth Rate (2015-2020) (Kiloton)
Figure 57. France Lipids Active Pharmaceutical Ingredient Sales and Growth Rate (2015-2020) (Kiloton)
Figure 58. Russia Lipids Active Pharmaceutical Ingredient Sales and Growth Rate (2015-2020) (Kiloton)
Figure 59. Italy Lipids Active Pharmaceutical Ingredient Sales and Growth Rate (2015-2020) (Kiloton)
Figure 60. Asia-Pacific Lipids Active Pharmaceutical Ingredient Revenue and Growth Rate (2015-2020) (USD Million)
Figure 61. Asia-Pacific Lipids Active Pharmaceutical Ingredient Sales Market Share by Regions 2019
Figure 62. Asia-Pacific Lipids Active Pharmaceutical Ingredient Revenue Market Share by Regions 2019
Figure 63. China Lipids Active Pharmaceutical Ingredient Sales and Growth Rate (2015-2020) (Kiloton)
Figure 64. Japan Lipids Active Pharmaceutical Ingredient Sales and Growth Rate (2015-2020) (Kiloton)
Figure 65. Korea Lipids Active Pharmaceutical Ingredient Sales and Growth Rate (2015-2020) (Kiloton)
Figure 66. India Lipids Active Pharmaceutical Ingredient Sales and Growth Rate (2015-2020) (Kiloton)
Figure 67. Southeast Asia Lipids Active Pharmaceutical Ingredient Sales and Growth Rate (2015-2020) (Kiloton)
Figure 68. South America Lipids Active Pharmaceutical Ingredient Revenue and Growth Rate (2015-2020) (USD Million)
Figure 69. South America Lipids Active Pharmaceutical Ingredient Sales Market Share by Countries in 2019
Figure 70. South America Lipids Active Pharmaceutical Ingredient Revenue Market Share by Countries in 2019
Figure 71. Brazil Lipids Active Pharmaceutical Ingredient Sales and Growth Rate (2015-2020) (Kiloton)
Figure 72. Argentina Lipids Active Pharmaceutical Ingredient Sales and Growth Rate (2015-2020) (Kiloton)
Figure 73. Middle East and Africa Lipids Active Pharmaceutical Ingredient Revenue and Growth Rate (2015-2020) (USD Million)
Figure 74. Middle East and Africa Lipids Active Pharmaceutical Ingredient Sales Market Share by Countries in 2019
Figure 75. Middle East and Africa Lipids Active Pharmaceutical Ingredient Revenue Market Share by Countries (2015-2020)
Figure 76. Middle East and Africa Lipids Active Pharmaceutical Ingredient Revenue Market Share by Countries in 2019
Figure 77. Saudi Arabia Lipids Active Pharmaceutical Ingredient Sales and Growth Rate (2015-2020) (Kiloton)
Figure 78. Egypt Lipids Active Pharmaceutical Ingredient Sales and Growth Rate (2015-2020) (Kiloton)
Figure 79. Turkey Lipids Active Pharmaceutical Ingredient Sales and Growth Rate (2015-2020) (Kiloton)
Figure 80. South Africa Lipids Active Pharmaceutical Ingredient Sales and Growth Rate (2015-2020) (Kiloton)
Figure 81. Global Lipids Active Pharmaceutical Ingredient Sales and Growth Rate (2021-2025) (Kiloton)
Figure 82. Global Lipids Active Pharmaceutical Ingredient Revenue and Growth Rate (2021-2025) (USD Million)
Figure 83. North America Sales Lipids Active Pharmaceutical Ingredient Market Forecast (2021-2025) (Kiloton)
Figure 84. Europe Sales Lipids Active Pharmaceutical Ingredient Market Forecast (2021-2025) (Kiloton)
Figure 85. Asia-Pacific Sales Lipids Active Pharmaceutical Ingredient Market Forecast (2021-2025) (Kiloton)
Figure 86. South America Sales Lipids Active Pharmaceutical Ingredient Market Forecast (2021-2025) (Kiloton)
Figure 87. Middle East & Africa Sales Lipids Active Pharmaceutical Ingredient Market Forecast (2021-2025) (Kiloton)
Figure 88. Sales Channel: Direct Channel vs Indirect Channel


【掲載企業】

CordenPharma International、Esperion Therapeutics、Sancilio&Company、Avanti Polar Lipids、Merck KGaA、VAV Life Sciences、Cerbios-Pharma SA、Cayman Chemical

★調査レポート[世界の脂質活性医薬品成分市場2020年:製造業者別、地域別、種類・用途別] (コード:GIR20SP05529)販売に関する免責事項を必ずご確認ください。
★調査レポート[世界の脂質活性医薬品成分市場2020年:製造業者別、地域別、種類・用途別]についてメールでお問い合わせ


◆H&Iグローバルリサーチのお客様(例)◆